Cell and Gene Therapies
SCRB 250QC
Subject & Catalog Number
Course Information
Description
Cell and gene therapies are among the newest breakthroughs in health care that can address difficult-to-treat diseases with no other treatment options. This course covers the history, development, and implementation of cell and gene therapies. Class time will consist of guest lectures from Harvard faculty or industry experts, in addition to discussion on primary/secondary research articles, case studies, and/or popular press articles. Students will participate in a capstone group project that proposes a novel cell or gene therapy, based on an unmet clinical need with a clear gene/cell target. Evaluation for the capstone project will be based on oral presentations of the project and an individual written assignment.
Course Notes
Undergraduates, MS/MBA in Biotechnology: Life Sciences, and HILS PhD students welcome. Recommended Prep: Undergraduates: Life and Physical Sciences A or Life Sciences 1a; Life Sciences 1b; SCRB 10, SCRB 50, or MCB60. PhD students: BCMP 301.
Available for Harvard Cross Registration
